BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 197067)

  • 1. Roles of cyclic structure and dehydro-form amino acid residue in a peptide antibiotic.
    Kitagawa T; Miura T; Taniyama H
    J Biochem; 1977 Jun; 81(6):1759-67. PubMed ID: 197067
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformations of (X-L-Pro-Y)2 cyclic hexapeptides. Preferred beta-turn conformers and implications for beta turns in proteins.
    Gierasch LM; Deber CM; Madison V; Niu CH; Blout ER
    Biochemistry; 1981 Aug; 20(16):4730-8. PubMed ID: 7295645
    [No Abstract]   [Full Text] [Related]  

  • 3. Conformational consequences of regio- and stereoselective disulfide bridge oxidation in a cyclic peptide.
    Malesević M; Jahreis G; Wawra S; Fischer G; Lücke C
    Chembiochem; 2008 Jan; 9(1):46-9. PubMed ID: 18072227
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereochemistry rules: a single stereocenter changes the conformation of a cyclic tetrapeptide.
    Li F; Bravo-Rodriguez K; Fernandez-Oliva M; Ramirez-Anguita JM; Merz K; Winter M; Lehmann CW; Sander W; Sanchez-Garcia E
    J Phys Chem B; 2013 Sep; 117(37):10785-91. PubMed ID: 24011400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon-13 nuclear magnetic resonance studies on a new antitubercular peptide antibiotic LL-BM547beta.
    McGahren WJ; Morton GO; Kunstmann MP; Ellestad GA
    J Org Chem; 1977 Apr; 42(8):1282-6. PubMed ID: 191583
    [No Abstract]   [Full Text] [Related]  

  • 6. Conformational and ion binding properties of a cyclic octapeptide, cyclo (Ala-Leu-Pro-Gly)2.
    Jois DS; Easwaran KR; Bednarek M; Blout ER
    Biopolymers; 1992 Aug; 32(8):993-1001. PubMed ID: 1420982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on viomycin IX. Amino acid derivatives on viomycin.
    Kitagawa T; Miura T; Takaishi C; Taniyama H
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformational studies on tocinamide and deaminotocinamide by 220 MHz nuclear magnetic resonance spectroscopy.
    Brewster AI; Glasel JA; Hruby VJ
    Proc Natl Acad Sci U S A; 1972 Jun; 69(6):1470-4. PubMed ID: 4504362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational studies of cyclic tetrapeptides. Evidence for a bis gamma-turn conformation for chlamydocin and Ala4-chlamydocin in nonpolar solvents.
    Rich DH; Kawai M; Jasensky RD
    Int J Pept Protein Res; 1983 Jan; 21(1):35-42. PubMed ID: 6826281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
    Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
    J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative α-helicity of cyclic pentapeptides in water.
    de Araujo AD; Hoang HN; Kok WM; Diness F; Gupta P; Hill TA; Driver RW; Price DA; Liras S; Fairlie DP
    Angew Chem Int Ed Engl; 2014 Jul; 53(27):6965-9. PubMed ID: 24828311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13C-nuclear magnetic magnetic resonance studies on viomycin and its related compounds.
    Kitagawa T; Miura T; Mori K; Taniyama H; Kawano K; Kyogoku Y
    Chem Pharm Bull (Tokyo); 1977 Feb; 25(2):280-4. PubMed ID: 192477
    [No Abstract]   [Full Text] [Related]  

  • 13. Native-like cyclic peptide models of a viral antigenic site: finding a balance between rigidity and flexibility.
    Valero ML; Camarero JA; Haack T; Mateu MG; Domingo E; Giralt E; Andreu D
    J Mol Recognit; 2000; 13(1):5-13. PubMed ID: 10679891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on viomycin. VIII. Selective modifications of the terminal amino groups of viomycin.
    Kitagawa T; Miura T; Takaishi M; Taniyama H
    Chem Pharm Bull (Tokyo); 1975 Sep; 23(9):2123-7. PubMed ID: 171092
    [No Abstract]   [Full Text] [Related]  

  • 15. Conformation and dynamics of a cyclic disulfide-bridged peptide: effects of temperature and solvent.
    Li F; Bravo-Rodriguez K; Phillips C; Seidel RW; Wieberneit F; Stoll R; Doltsinis NL; Sanchez-Garcia E; Sander W
    J Phys Chem B; 2013 Apr; 117(13):3560-70. PubMed ID: 23514118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and dynamic properties of ion-specific antibiotics.
    Grell E; Funck T; Eggers F
    Membranes; 1975; 3():1-126. PubMed ID: 53774
    [No Abstract]   [Full Text] [Related]  

  • 17. Turns in peptides and proteins.
    Rose GD; Gierasch LM; Smith JA
    Adv Protein Chem; 1985; 37():1-109. PubMed ID: 2865874
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of protein-ligand interactions by photocleavage of a cyclic peptide using phosphatidylinositol 3-kinase SH3 domain as model system.
    Takahashi I; Kuroiwa S; Lindfors HE; Ndamba LA; Hiruma Y; Yajima T; Okishio N; Ubbink M; Hirota S
    J Pept Sci; 2009 Jun; 15(6):411-6. PubMed ID: 19378350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic peptides. 17. Metal and amino acid complexes of cyclo(pro-gly)4 and analogues studied by nuclear magnetic resonance and circular dichroism.
    Madison V; Deber CM; Blout ER
    J Am Chem Soc; 1977 Jul; 99(14):4788-98. PubMed ID: 874230
    [No Abstract]   [Full Text] [Related]  

  • 20. Conformational mobility in cyclic oligopeptides.
    Kopple KD; Bean JW; Bhandary KK; Briand J; D'Ambrosio CA; Peishoff CE
    Biopolymers; 1993 Jul; 33(7):1093-9. PubMed ID: 8102073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.